PATENT CLAIM ANALYSIS

Application Number: 15991998
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["424", "001490"]

Abstract:
The invention provides antibodies that specifically bind to the LG4-5 modules of the G domain of laminin α4. The antibodies can preferentially stain cancer or tumor cells or tissue. The antibodies can be used for detecting cancer, evaluating the efficacy of a cancer therapy, treating cancer, and treating obesity or obesity-related diseases, among other applications.

Claim (Index 96):
The method of  claim 64 , wherein binding of the antibody to the biological sample is at least 2-fold greater than the binding of the antibody to the control sample.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 93.0
- Lexical Diversity: 1.47619
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14656619', '15201423', '15201416', '15125570', '15201429']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7002834031352301
- 35 USC 102 Novelty (BERT): 0.6013857187188169
- Combined Prediction Score: 0.6903936346935887
- Mean Citation Score: 401.37045
- Max Citation Score: 611.8948
- Similarity Product: 411.0550720396757

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test